No Data
Tianjin Ringpu Bio-Technology (300119.SZ): Obtained a new veterinary drug registration certificate.
On November 28, Glonghui reported that tianjin ringpu bio-technology (300119.SZ) announced that according to the "Regulations on Veterinary Drugs" and "Measures for the Registration of Veterinary Drugs", tianjin ringpu bio-technology Co., Ltd. and its subsidiary, ringpu (tianjin) bio-pharmaceutical Co., Ltd., shanxi ruixiang bio-pharmaceutical Co., Ltd., and hubei longxiang pharmaceutical technology Co., Ltd. recently obtained the "New Veterinary Drug Registration Certificate" issued by the Ministry of Agriculture and Rural Affairs. The related new veterinary drugs are hydrochloride vonipinol dihydrate and hydrochloride vonipinol dihydrate soluble powder. In the context of the global antibiotic reduction initiative, hydrochloride vonipinol dihydrate soluble powder is also related to truncated side.
Tianjin Ringpu Bio-Technology Co.,Ltd. (SZSE:300119) Shares Could Be 42% Below Their Intrinsic Value Estimate
Guolian Securities: Hog farming prosperity rises, pet and fodder companies' prosperity is on the rise.
In Q3 2024, the revenue of the pig sector increased compared to the previous quarter. 15 listed pig companies achieved a revenue of 126.516 billion yuan in the third quarter of 2024, an increase of 3.20% year-on-year and 18.01% quarter-on-quarter.
tianjin ringpu bio-technology (300119.SZ): has repurchased a total of 1.5483 million shares.
Grain In 11th November, Tianjin Ringpu Bio-Technology (300119.SZ) announced that on November 8, 2024, the company implemented its first repurchase. The company repurchased 730,751 shares for the first time through centralized competitive bidding trading, accounting for 0.1569% of the company's current total share capital. The lowest transaction price was RMB 19.14 per share, the highest transaction price was RMB 19.49 per share, and the total amount paid was RMB 14.1636 million (excluding trading expenses). As of the date of the announcement, the company's repurchase plan has repurchased shares through centralized competitive bidding trading method.
Tianjin Ringpu Bio-Technology Plans to Acquire 15% Stake in Zhongrui Huapu Technology
tianjin ringpu bio-technology (300119.SZ) is planning to acquire 15% equity of Zhong Rui Huapu to improve its strategic layout in the pet health sector.
Zhijian Financial APP news, tianjin ringpu bio-technology (300119.SZ) issued an announcement, to continue to improve the company's strategic layout in the pet health sector...
Earnings Working Against Tianjin Ringpu Bio-Technology Co.,Ltd.'s (SZSE:300119) Share PriceNo Data
No Data
